Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

TNF-alpha inhibitors disclosed by Celgene

Jan. 23, 1998

Sheffield proceeds with development of respiratory drugs in its MSI

Jan. 20, 1998

Daiichi and Sumitomo to copromote antiallergic drug in Japan

Jan. 19, 1998

Inhibitors of iNOS developed at Astra

Jan. 16, 1998

Anti-IL-4 antibodies from Schering-Plough

Jan. 16, 1998

New PAF antagonists disclosed by Korean investigators

Jan. 15, 1998

Schering-Plough discovers dual NK1/NK2 antagonists from fungal strain

Jan. 15, 1998

Antiallergic efficacy of dual-action compound demonstrated in preclinical models

Jan. 14, 1998

New tachykinin antagonists from Schering-Plough

Jan. 8, 1998

FR-167653 protects against ischemia-reperfusion injury in lung in canine model

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...